Clinical trial on the search for a hyperemia evaluation system using a conjunctival allergen challenge test

Phase 2

• Conditions: Patients with asymptomatic allergic conjunctivitis

• Registration Number: JPRN-jRCTs031210206
• Lead Sponsor: Atsuki Fukushima

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-07-26
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 24

Inclusion Criteria

1 At the time of obtaining consent
1)Persons aged between 20 and 50 who can obtain written consent
2)Gender :Male /Female
3) Persons with subjective symptoms and objective findings associated with allergic conjunctivitis in the past
2 Until the visit 2 end
4)No symptoms or findings of pruritus and conjunctival hyperemia in both eyes before antigen induction
5)Those with an eye itching sensation and conjunctival hyperemia grade 2 or higher due to antigen induction in both eyes.

Exclusion Criteria

1 At the time of obtaining consent
1)Inflammatory eye disease (vernal conjunctivitis,atopic conjunctivitis, blepharitis etc. ) complications of the external or anterior segment of the eye
2)Contact lens wearers
3)Oher patients who have been considered inappropriate as clinical trial subjects by investigator or sub- investigator.

Study & Design

• Study Type: Interventional
• Study Design: Not specified